WCN26-388 WHAT ARE THE BIOMARKER THRESHOLDS FOR CONSIDERING IRON OVERLOAD SCREENING WITH T2*-WEIGHTED MRI IN PATIENTS WITH CKD?

Read full text Summarise with VIRAT
Authors: Abdulqadir J. Nashwan, Abdullah Hamad, Hassan Ali Al-Malki, Maryam Al Kuwari, Ali Al‐Radaideh, Mohamed A. Yassin
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Anemia management in patients with chronic kidney disease (CKD) relies heavily on intravenous iron supplementation, particularly in patients on hemodialysis. However, excessive iron administration may lead to iron overload, a condition associated with hepatic, cardiac, and endocrine complications, as well as other complications. Clinical guidelines primarily use serum ferritin and transferrin saturation (TSAT) to assess iron status, yet these biomarkers lack specificity in the context of inflammation.

Fields of Study & Subjects

Iron Metabolism and Disorders Erythropoietin and Anemia Treatment Hemoglobinopathies and Related Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104188–104188
Publication date
25 March 2026
Language
EN